Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of a 6-Month Treatment With IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose

NCT00891813 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00891813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00891813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of a 6-Month Treatment With IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose
Lead sponsor
Abbott
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2009
Completion date
September 30, 2010
Enrollment
100 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis, hypercalcemia, parathyroid hormone, renal insufficiency, chronic, secondary hyperparathyroidism